1. Home
  2. SLS vs WBX Comparison

SLS vs WBX Comparison

Compare SLS & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • WBX
  • Stock Information
  • Founded
  • SLS 2012
  • WBX 2015
  • Country
  • SLS United States
  • WBX Spain
  • Employees
  • SLS N/A
  • WBX N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • WBX Industrial Specialties
  • Sector
  • SLS Health Care
  • WBX Consumer Discretionary
  • Exchange
  • SLS Nasdaq
  • WBX Nasdaq
  • Market Cap
  • SLS 100.6M
  • WBX 119.6M
  • IPO Year
  • SLS N/A
  • WBX N/A
  • Fundamental
  • Price
  • SLS $1.27
  • WBX $0.51
  • Analyst Decision
  • SLS
  • WBX Buy
  • Analyst Count
  • SLS 0
  • WBX 3
  • Target Price
  • SLS N/A
  • WBX $1.17
  • AVG Volume (30 Days)
  • SLS 4.1M
  • WBX 331.8K
  • Earning Date
  • SLS 03-27-2025
  • WBX 02-26-2025
  • Dividend Yield
  • SLS N/A
  • WBX N/A
  • EPS Growth
  • SLS N/A
  • WBX N/A
  • EPS
  • SLS N/A
  • WBX N/A
  • Revenue
  • SLS N/A
  • WBX $179,622,844.00
  • Revenue This Year
  • SLS N/A
  • WBX $18.23
  • Revenue Next Year
  • SLS N/A
  • WBX $21.57
  • P/E Ratio
  • SLS N/A
  • WBX N/A
  • Revenue Growth
  • SLS N/A
  • WBX 16.10
  • 52 Week Low
  • SLS $0.77
  • WBX $0.41
  • 52 Week High
  • SLS $1.84
  • WBX $1.73
  • Technical
  • Relative Strength Index (RSI)
  • SLS 50.97
  • WBX 49.90
  • Support Level
  • SLS $1.20
  • WBX $0.45
  • Resistance Level
  • SLS $1.37
  • WBX $0.62
  • Average True Range (ATR)
  • SLS 0.14
  • WBX 0.04
  • MACD
  • SLS -0.02
  • WBX 0.01
  • Stochastic Oscillator
  • SLS 10.94
  • WBX 37.43

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.

Share on Social Networks: